2016
Salinaro F, Meier-Ewert HK, Miller E, Shivda P, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. European Heart Journal – Cardiovascular Imaging, 0, 1-8, 2016 Dec 12. View in: PubMed
Ruberg FL, Fontana M, Gillmore JD. Should histologic determination of Amyloid load determine management decisions in light-chain Amyloidosis? J Am Coll Cardiol. 68(22):2493-2494, 2016 Dec 6. View in: PubMed
Nolin AC, Mulhern RM, Panchenko MV, Pisarek-Horowitz A, Wang Z, Shirihai O, Borkan SC, Havasi A. Proteinuria causes dysfunctional autophagy in the proximal tubule.
Prokaeva T, Spencer B, Sun F, O’Hara RM, Seldin DC, Connors LH, Sanchorawala V. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. 23(4):214-220, 2016 Dec. View in: PubMed
Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. 1(8):880-889, 2016 Nov 1. View in: PubMed
Havasi A, Stern L, Lo S, Sun F, Sanchorawala V. Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation.
Havasi A, Lu W, Cohen HT, Beck LH Jr, Wang Z, Igwebuike C, Borkan SC. Blocking peptides & molecular mimicry as treatment for kidney disease.
Menn-Josephy H, Lee CS, Nolin A, Christov M, Rybin DV, Weinberg JM, Henderson J, Bonegio R, Havasi A. Renal interstitial fibrosis: an imperfect predictor of kidney disease progression in some patient cohorts. Am J Nephrol. 44(4):289-299, 2016 Sep 15. View in: PubMed
Sanchorawala V, Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC. Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial. Blood, 128(8):1059-1062, 2016. View in: PubMed
Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL. Can 99m-Tc-Pyrophosphate aid in early detection of cardiac involvement in asymptomatic variant TTR Amyloidosis? JACC Cardiovasc Imaging. pii: S1936-878X(16)30443-0, 2016 Aug 20. View in: PubMed
Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 133(24):2404-12. 2016 Jun 14. View in: PubMed
Lee SY, Brauneis D, Stern L, Sanchorawala V. Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney. Hematol Oncol Stem Cell Ther, 9(2):86-8, 2016. View in: PubMed
Havasi A, Dong Z. Autophagy and tubular cell death in the kidney.
Sanchorawala V, Gale RP. David C Seldin, MD, PhD: scientist, clinician, teacher, gentleman, 1957-2015. Bone Marrow Transplant, 51(3):323, 2016. View in: PubMed
Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, and Seldin DC. Heart failure due to age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study. Circulation, 133:282-290, 2016. View in: PubMed
Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM. Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Haematologica, 101(1):86-90, 2016. View in: PubMed